Evidence map›Paper›PMID 42092894›Full record

ArticleBMC medical genomics2026

A novel pathogenic variant in folliculin identified in a Chinese family with BHD syndrome.

Na Xing, Yi-Shuai Li, Wei Wei, Yong Feng

Abstract read
In one paragraph

Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Na XingDepartment of Endocrinology, Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, Hebei, 050011, China.
Yi-Shuai LiDepartment of Thoracic Surgery, Hebei Chest Hospital, Shijiazhuang, Hebei, 050000, China.
Wei WeiOutpatient department, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China.
Yong FengDepartment of Thoracic Surgery and Infectious Diseases, Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, Hebei, 050011, China. 48101685@hebmu.edu.cn.

Funding

Medical Science Research Project of Hebei (No.20201053).
6 · The paper itself

Abstract

backgroundThis study aimed to investigate FLCN gene variants in Chinese patients presenting with familial spontaneous pneumothorax associated with Birt-Hogg-Dubé syndrome (BHDS).

methodsA Chinese family with a history of familial spontaneous pneumothorax linked to BHD was analyzed. Genetic screening of the folliculin (FLCN) gene was conducted using next-generation sequencing (NGS) technology.

resultsA nonsense variant (c.439 C > T) in the FLCN gene was identified in six individuals within the family. This variant, previously unreported in the Chinese population, results in the substitution of glutamine at the 147th amino acid position in exon 6 with a premature stop codon. The variant is hypothesized to induce nonsense-mediated mRNA decay, potentially leading to the absence of functional protein expression, which may underlie the pathogenesis of pneumothorax in this family.

conclusionsThe findings elucidate the FLCN variant associated with familial spontaneous pneumothorax in BHD, thereby expanding the variantion spectrum of the FLCN gene and providing insights into the molecular mechanisms of this condition.

Indexed as

Birt-Hogg-Dube SyndromePneumothoraxProto-Oncogene ProteinsTumor Suppressor ProteinsAdultCodon, NonsenseEast Asian PeopleFemaleHumansMalePedigreeCodon, NonsenseFLCN protein, humanProto-Oncogene ProteinsTumor Suppressor ProteinsBirt-Hogg-Dubé syndromeClinical geneticsFamilial spontaneous pneumothoraxFLCN geneVariant analysis

Identifiers

PMID42092894
PMCPMC13321696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.